[{"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA040183"], "brand_name": ["METHYLPREDNISOLONE"], "generic_name": ["METHYLPREDNISOLONE"], "manufacturer_name": ["American Health Packaging"], "product_ndc": ["68084-149"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METHYLPREDNISOLONE"], "rxcui": ["259966"], "spl_id": ["2b248f3e-121b-f738-e063-6294a90a264d"], "spl_set_id": ["97256c7e-5694-4148-926f-594b9d5c34f4"], "package_ndc": ["68084-149-11", "68084-149-01"], "original_packager_product_ndc": ["0603-4593"], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["X4W7ZR7023"]}, "product_type": "Drugs", "event_id": "69511", "recalling_firm": "American Health Packaging", "address_1": "2550 John Glenn Ave", "address_2": "Suite A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0043-2015", "product_description": "MethylPREDNISolone Tablets, USP, 4 mg, 100 unit dose blisters, Packaged and Distributed by: American Health Packaging, Columbus, OH ---- Carton of 100 NDC 68084-149-01, Individual Dose NDC 68084-149-11", "product_quantity": "2,005 cartons", "reason_for_recall": "Subpotent; 6 month stability time point", "recall_initiation_date": "20141010", "center_classification_date": "20141023", "termination_date": "20150601", "report_date": "20141029", "code_info": "AHP Lot #: 134124 and 140364  Expiration Date of both lots: 05/2015  Carton NDC #: 68084-149-01  Single Dose NDC #: 68084-149-11", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 175 mcg may have potentially been mislabeled as one of the following drugs:  LEVOTHYROXINE SODIUM, Tablet, 88 mcg, NDC 00781518392, Pedigree: AD46265_34, EXP: 5/15/2014;  hydrOXYzine PAMOATE, Capsule, 100 mg, NDC 00555032402, Pedigree: W003008, EXP: 6/11/2014.", "address_2": "", "product_quantity": "200 Tablets", "code_info": "LEVOTHYROXINE SODIUM, Tablet, 175 mcg has the following codes:   Pedigree: AD46265_37, EXP: 5/15/2014;  Pedigree: W003009, EXP: 6/11/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LEVOTHYROXINE SODIUM, Tablet, 175 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00527135001.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-923-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0159-2015", "product_description": "Tri-mix ST9-B, 30 mg/2 mg/100 mcg/mL (papaverine, phentolamine mesylate, alprostadil) injectable packaged in a clear glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "100 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 07202014@8, Exp 10/18/2014", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: VITAMIN B COMPLEX W/C, Tablet, 0 mg may have potentially been mislabeled as one of the following drugs:  MULTIVITAMIN/ MULTIMINERAL/ LUTEIN, Capsule, 0 mg, NDC 24208063210, Pedigree: AD21846_40, EXP: 5/2/2014;  CALCIUM CARBONATE/CHOLECALCIFEROL, Tablet, 600 mg/800 units, NDC 00005550924, Pedigree: AD52993_1, EXP: 5/17/2014;  MULTIVITAMIN/ MULTIMINERAL/ LUTEIN, Capsule, 0, ND", "address_2": "", "product_quantity": "780 Tablets", "code_info": "VITAMIN B COMPLEX W/C, Tablet, 0 mg has the following codes:   Pedigree: AD21846_43, EXP: 5/1/2014;  Pedigree: AD52993_31, EXP: 5/17/2014;  Pedigree: AD60240_48, EXP: 5/22/2014;  Pedigree: W003321, EXP: 6/19/2014;  Pedigree: AD46419_7, EXP: 5/16/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "VITAMIN B COMPLEX W/C, Tablet, 0 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904026013.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-1016-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Huntsville", "address_1": "120 Vintage Dr NE", "reason_for_recall": "Superpotent Drug: Qualitest Pharmaceuticals is initiating a recall of three flavors of Acetaminophen Oral Suspension Liquid 160mg/5mL for failure of the product assay at the 12 month timepoint.", "address_2": "", "product_quantity": "181908 units", "code_info": "Codes:  L049J12A, L067M12A, L079B13A, L079B13B, L077E13A, L010H13A, L011J13A, L101K13A", "center_classification_date": "20141021", "distribution_pattern": "Nationwide", "state": "AL", "product_description": "CHILDREN'S Q-PAP, Acetaminophen, ORAL SUSPENSION, BUBBLE GUM FLAVOR, Active ingredient (in each 5 mL = 1 tsp) Acetaminophen USP 160 mg, 4 FL OZ (118 mL), Made in the USA for Qualitest Pharmaceuticals, Huntsville, AL 35811, NDC 0603-0841-54, OTC", "report_date": "20141029", "classification": "Class II", "openfda": {}, "recalling_firm": "Qualitest Pharmaceuticals", "recall_number": "D-0037-2015", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "69014", "termination_date": "20160202", "more_code_info": "", "recall_initiation_date": "20140806", "postal_code": "35811-8216", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; tiZANidine HCl Tablet, 1 mg (1/2 of 2 mg) may be potentially mislabeled as     PYRIDOXINE HCL, Tablet, 50 mg, NDC 00536440801, Pedigree: AD60428_10, EXP: 5/22/2014.", "address_2": "", "product_quantity": "299 Tablets", "code_info": "tiZANidine HCl, Tablet, 1 mg (1/2 of 2 mg) has the following code    Pedigree: AD60272_52, EXP: 5/22/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "tiZANidine HCl Tablet, 1 mg (1/2 of 2 mg), Rx only, Distributed by: AidaPak Service, LLC, NDC 55111017915", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-620-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: CALCIUM ACETATE, Tablet, 667 mg may have potentially been mislabeled as one of the following drugs:   ASCORBIC ACID, Tablet, 250 mg, NDC 00904052260, Pedigree: AD30028_34, EXP: 5/7/2014;  HYOSCYAMINE SULFATE ODT, Tablet, 0.125 mg, NDC 00574024701, Pedigree: W003614, EXP: 6/25/2014.", "address_2": "", "product_quantity": "401 Tablets", "code_info": "CALCIUM ACETATE, Tablet, 667 mg has the following codes:   Pedigree: AD23098_1, EXP: 5/8/2014;  Pedigree: W003637, EXP: 6/25/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "CALCIUM ACETATE, Tablet, 667 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00574011302.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-955-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: ASCORBIC ACID, CHEW Tablet, 500 mg may have potentially been mislabeled as the following drug:  PHENOL, LOZENGE, 29 mg, NDC 00068021918, Pedigree: AD60428_4, EXP: 5/22/2014.", "address_2": "", "product_quantity": "100 CHEW Tablets", "code_info": "ASCORBIC ACID, CHEW Tablet, 500 mg has the following codes:   Pedigree: AD60240_54, EXP: 5/22/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ASCORBIC ACID, CHEW Tablet, 500 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904052660.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-1021-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; LOSARTAN POTASSIUM, Tablet, 25 mg may be potentially mislabeled as    DISOPYRAMIDE PHOSPHATE, Capsule, 150 mg, NDC 00093312901, Pedigree: AD65323_4, EXP: 5/29/2014.", "address_2": "", "product_quantity": "180 Tablets", "code_info": "LOSARTAN POTASSIUM, Tablet, 25 mg has the following code    Pedigree: AD65323_10, EXP: 5/29/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LOSARTAN POTASSIUM, Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 13668011390", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-511-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Nixa", "state": "MO", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "67228", "recalling_firm": "Schindele Enterprises dba Midwest Wholesale", "address_1": "617 N Althea Ave", "address_2": "N/A", "postal_code": "65714-7432", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed to PA, IL, TX, IA, GA, CT, FL, CA, LA, NY, MD, NV, and WI", "recall_number": "D-1340-2014", "product_description": "XZEN PLATINUM, 750 mg, Distributed by: XZEN, Los Angeles, CA.", "product_quantity": "89 blister packs", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.", "recall_initiation_date": "20140109", "center_classification_date": "20140520", "termination_date": "20150203", "report_date": "20140528", "code_info": "Lot 130520PL Exp. 05/31/2017"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; CITALOPRAM Tablet, 10 mg may be potentially mislabeled as    OXYBUTYNIN CHLORIDE, Tablet, 5 mg, NDC 00603497521, Pedigree: AD52778_61, EXP: 5/20/2014;  COENZYME Q-10, Capsule, 30 mg, NDC 00904501546, Pedigree: W002814, EXP: 6/7/2014.", "address_2": "", "product_quantity": "299 Tablets", "code_info": "CITALOPRAM, Tablet, 10 mg has the following codes    Pedigree: AD56921_1, EXP: 5/21/2014;  Pedigree: W002844, EXP: 6/7/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "CITALOPRAM Tablet, 10 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 57664050788", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-630-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: PYRIDOXINE HCL, Tablet, 100 mg may have potentially been mislabeled as one of the following drugs:  CYANOCOBALAMIN, Tablet, 1000 mcg, NDC 00536355601, Pedigree: AD73627_29, EXP: 5/30/2014;  COENZYME Q-10, Capsule, 100 mg, NDC 37205055065, Pedigree: W003871, EXP: 6/27/2014;  VITAMIN B COMPLEX PROLONGED RELEASE, Tablet, 0 mg, NDC 40985022251, Pedigree: AD76686_1, EXP: 5/31/201", "address_2": "", "product_quantity": "299 Tablets", "code_info": "PYRIDOXINE HCL, Tablet, 100 mg has the following codes:   Pedigree: AD73627_32, EXP: 5/30/2014;  Pedigree: W003872, EXP: 6/27/2014;  Pedigree: AD76686_4, EXP: 5/31/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PYRIDOXINE HCL, Tablet, 100 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536440901.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-942-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; CYANOCOBALAMIN, Tablet, 1000 mcg may be potentially mislabeled as     VITAMIN B COMPLEX W/C, Tablet, NDC 00904026013, Pedigree: AD21846_43, EXP: 5/1/2014;  NIACIN TR, Capsule, 500 mg, NDC 00904063160, Pedigree: AD46257_22, EXP: 5/15/2014;  chlorproMAZINE HCl, Tablet, 50 mg, NDC 00832030200, Pedigree: AD32973_4, EXP: 5/9/2014;  PRENATAL MULTIVITAMIN/MULTIMINERAL, Tablet, NDC", "address_2": "", "product_quantity": "1,821 Tablets", "code_info": "CYANOCOBALAMIN, Tablet, 1000 mcg has the following codes    Pedigree: AD21846_46, EXP: 5/1/2014;  Pedigree: AD46257_59, EXP: 5/15/2014;  Pedigree: AD32582_3, EXP: 5/9/2014;  Pedigree: AD60240_51, EXP: 5/22/2014;  Pedigree: W002839, EXP: 6/7/2014;  Pedigree: W003026, EXP: 6/12/2014;  Pedigree: W003075, EXP: 6/12/2014;  Pedigree: W003322, EXP: 6/19/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "CYANOCOBALAMIN, Tablet, 1000 mcg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904421713", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-466-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Lewis Center", "address_1": "741 Radio Dr", "reason_for_recall": "Labeling: Label Mix up; product labeled to contain Docusate Sodium 240mg instead of Docusate Calcium 240mg", "address_2": "", "product_quantity": "99/240 mg softgel caps", "code_info": "Lot #: 002H79, Use By: 06/19/2013, NDC: 00904-5779-60", "center_classification_date": "20140723", "distribution_pattern": "Product was shipped to the following states: CO, MA, OH, TX & WY.", "state": "OH", "product_description": "Docusate Calcium Softgel Capsules, 240 mg, OTC, packaged and labeled to contain Docusate Sodium 240mg, Repackaged By: Shamrock Medical Solutions Lewis Center, Ohio, Mfg: Major Pharmaceuticals, Livonia, MI  NDC 00904-5779-60", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Shamrock Medical Solutions Group LLC", "recall_number": "D-1451-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "64611", "termination_date": "20140731", "more_code_info": "", "recall_initiation_date": "20110927", "postal_code": "43035-7134", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Sugar Land", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68304", "recalling_firm": "Healix Infusion Therapy, Inc.", "address_1": "1075 W Park One Dr", "address_2": "", "postal_code": "77478-2576", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Texas", "recall_number": "D-1422-2014", "product_description": "BUPivacaine HCl 0.25% Preservative Free (2.5 mg/mL) 500 mL in On-Q C-bloc (2-14 mL/hr) bag, Healix Infusion Therapy, Inc., 1075 West Park One Drive, Suite 200, Sugar Land, Texas  77478, NDC 75901-7210-53.", "product_quantity": "10 bags", "reason_for_recall": "Presence of Particulate Matter:  The bupivacaine HCl injection used to compound this lot of BUPivacaine HCl 0.25% Preservative Free 500 mL in On-Q C-bloc was recalled by the supplier due to a customer complaint of visible particles embedded in the glass vial.", "recall_initiation_date": "20140213", "center_classification_date": "20140707", "termination_date": "20160216", "report_date": "20140716", "code_info": "Lot #: 6156-0, Exp 03/07/14", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; LACTOBACILLUS ACIDOPHILUS Capsule may be potentially mislabeled as    CHOLECALCIFEROL, Tablet, 2000 units, NDC 00904615760, Pedigree: AD65311_1, EXP: 5/24/2014;  PANCRELIPASE DR, Capsule, 24000 /76000 /120000 USP units, NDC 00032122401, Pedigree: AD65457_4, EXP: 5/24/2014.", "address_2": "", "product_quantity": "2,392 Capsules", "code_info": "LACTOBACILLUS ACIDOPHILUS, Capsule has the following codes    Pedigree: AD65311_7, EXP: 5/24/2014;  Pedigree: AD65311_4, EXP: 5/24/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LACTOBACILLUS ACIDOPHILUS Capsule, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 54629011101", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-618-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: PROGESTERONE, Capsule, 100 mg may be potentially mislabeled as the following drug:   LEVOTHYROXINE SODIUM, Tablet, 12.5 mcg (1/2 of 25 mcg), NDC 00527134101, Pedigree: AD46265_40, EXP: 5/15/2014.", "address_2": "", "product_quantity": "500 Capsules", "code_info": "PROGESTERONE, Capsule, 100 mg has the following codes:   Pedigree: AD46320_1, EXP: 5/15/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PROGESTERONE, Capsule, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00032170801.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-786-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0183-2015", "product_description": "CITRIC ACID/GLUCONOLACTONE MAGNES CARB (RENACIDIN), 66/1.98/31.77 mg/mL, solution for irrigation, 30 mL plastic syringe, RX, Creative Compounds, Wilsonville, OR 97070", "product_quantity": "900 mL", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #: 20140908@2, discard date: 10/23/2014"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0120-2015", "product_description": "Phenylephrine 10% opthalmic solution packaged in an opaque squeeze bottle eye dropper, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "100 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 03222014@1, Exp 9/18/2014", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; ZINC SULFATE, Capsule, 220 mg (50 mg Elem Zn) may be potentially mislabeled as    PHOSPHORUS, Tablet, 250 mg, NDC 64980010401, Pedigree: AD56916_1, EXP: 5/21/2014.", "address_2": "", "product_quantity": "99 Capsules", "code_info": "ZINC SULFATE, Capsule, 220 mg (50 mg Elem Zn) has the following code    Pedigree: AD57624_1, EXP: 5/9/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ZINC SULFATE, Capsule, 220 mg (50 mg Elem Zn), Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904533260", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-479-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1110 mg may be potentially mislabeled as    LACTOBACILLUS GG, Capsule, NDC 49100036374, Pedigree: AD70655_8, EXP: 5/29/2014;  PYRIDOXINE HCL, Tablet, 100 mg, NDC 00536440901, Pedigree: AD73627_32, EXP: 5/30/2014.", "address_2": "", "product_quantity": "210 Capsules", "code_info": "OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1110 mg has the following codes    Pedigree: AD70655_20, EXP: 5/29/2014;  Pedigree: AD73627_35, EXP: 5/30/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1110 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 11523726503", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-504-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Irvine", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA050821"], "brand_name": ["CEFEPIME HYDROCHLORIDE AND DEXTROSE"], "generic_name": ["CEFEPIME HYDROCHLORIDE"], "manufacturer_name": ["B. Braun Medical Inc."], "product_ndc": ["0264-3193", "0264-3195"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["CEFEPIME HYDROCHLORIDE"], "rxcui": ["1665088", "1665093"], "spl_id": ["afe666d5-84ec-45a7-ae00-c643b4eaeb35"], "spl_set_id": ["57517a0e-ec1b-4605-a7cc-7e3801158ec9"], "package_ndc": ["0264-3193-11", "0264-3195-11"], "is_original_packager": [true], "unii": ["I8X1O0607P"]}, "product_type": "Drugs", "event_id": "66913", "recalling_firm": "B. Braun Medical Inc", "address_1": "2525 McGaw Ave", "address_2": "", "postal_code": "92614-5841", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Puerto Rico and Spain", "recall_number": "D-1267-2014", "product_description": "Cefepime for Injections USP and Dextrose Injection USP, 1 g in Duplex, 50 mL Container, Catalog Number 3193-11, For IV Use Only, Single Dose, Sterile, Rx Only, B Braun Medical Inc., Irvine CA 92614-5895, NDC 0264-3193-11", "product_quantity": "22,248 units", "reason_for_recall": "Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.", "recall_initiation_date": "20131121", "center_classification_date": "20140425", "termination_date": "20141204", "report_date": "20140507", "code_info": "Lot# H2L712, Exp 09/14", "more_code_info": ""}, {"country": "United States", "city": "Asheville", "address_1": "752 Biltmore Ave", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "All lot numbers within expiry.", "center_classification_date": "20140304", "distribution_pattern": "NC", "state": "NC", "product_description": "Ethanol 20% ophthal.", "report_date": "20140312", "classification": "Class II", "openfda": {}, "recalling_firm": "Natures Pharmacy & Compounding Center", "recall_number": "D-1110-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66856", "termination_date": "20140424", "more_code_info": "", "recall_initiation_date": "20131101", "postal_code": "28803-2558", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; RIBAVIRIN, Capsule, 200 mg may be potentially mislabeled as    MODAFINIL, Tablet, 50 mg (1/2 of 100 MG Tablet), NDC 55253080130, Pedigree: AD21787_4, EXP: 5/1/2014;  DESIPRAMINE HCL, Tablet, 50 mg, NDC 45963034302, Pedigree: AD30140_7, EXP: 5/7/2014.", "address_2": "", "product_quantity": "168 Capsules", "code_info": "RIBAVIRIN, Capsule, 200 mg has the following codes    Pedigree: AD21790_37, EXP: 4/30/2014;  Pedigree: AD30140_13, EXP: 4/30/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "RIBAVIRIN, Capsule, 200 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 68382026007", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-727-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "52 units", "code_info": "Rx # 29011, Exp 05/21/14; Rx # 29141, Exp 05/22/14; Rx # 29171, Exp 05/20/14", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Cefepime 1 gm/100 mL 0.9%NS, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 29011, Discard After 05/21/14, Rx # 29141, Discard After 05/22/14, Rx # 29171, Discard After 05/20/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1479-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: VENLAFAXINE HCL, Tablet, 25 mg may have potentially been mislabeled as one of the following drugs:  sitaGLIPtin PHOSPHATE, Tablet, 50 mg, NDC 00006011231, Pedigree: W002824, EXP: 6/7/2014;  LEVOTHYROXINE SODIUM, Tablet, 112 mcg, NDC 00378181101, Pedigree: W003847, EXP: 6/27/2014;  LITHIUM CARBONATE ER, Tablet, 450 mg, NDC 00054002025, Pedigree: AD62796_1, EXP: 5/22/2014.", "address_2": "", "product_quantity": "300 Tablets", "code_info": "VENLAFAXINE HCL, Tablet, 25 mg has the following codes:   Pedigree: W002825, EXP: 12/31/2013;  Pedigree: W003860, EXP: 6/27/2014;  Pedigree: AD62796_4, EXP: 5/22/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "VENLAFAXINE HCL, Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093019901.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-822-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67605", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1096-2014", "product_description": "0.9% Sodium Chloride Injection, USP 1000 mL Flexible Container, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7983-09", "product_quantity": "603,768 bags", "reason_for_recall": "Lack of Assurance of Sterility:Solution leaking through the port cover of the primary container, which was identified during a retain sample visual inspection.", "recall_initiation_date": "20140211", "center_classification_date": "20140303", "termination_date": "20150317", "report_date": "20140312", "code_info": "Lot 34-609-FW; Exp 10/15", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: FLUVASTATIN, Capsule, 20 mg may have potentially been mislabeled as the following drug:  ACETAMINOPHEN/ BUTALBITAL/ CAFFEINE, Tablet, 325 mg/50 mg/40 mg, NDC 00603254421, Pedigree: W002654, EXP: 6/4/2014.", "address_2": "", "product_quantity": "90 Capsules", "code_info": "FLUVASTATIN, Capsule, 20 mg has the following codes:   Pedigree: 00378802077, EXP: W002655.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "FLUVASTATIN, Capsule, 20 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378802077.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-910-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Ferndale", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67723", "recalling_firm": "Terra-Medica Inc.", "address_1": "1465 Slater Rd", "address_2": "N/A", "postal_code": "98248-8919", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Products were distributed US Nationwide, to Canada, to Philippines, and through internet sales.", "recall_number": "D-1210-2014", "product_description": "Pleo Ex DROPS 5X, 10 ml bottles, Homeopathic Antifungal Medicine, OTC Only.  Made in Germany for: SANUM USA Corp., 1465 Slater Road, Ferndale, WA 98248 by Sanum-Kehlbeck GMbH & Co. KG. NDC: 49807-1003-1.", "product_quantity": "3440 bottles", "reason_for_recall": "Penicillin Cross Contamination", "recall_initiation_date": "20140303", "center_classification_date": "20140407", "termination_date": "20140730", "report_date": "20140416", "code_info": "Batch # 07011; EXP: December 2015; Batch # 09043, EXP: March 2108."}, {"status": "Terminated", "city": "Chesterfield", "state": "MO", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "69076", "recalling_firm": "ChiroNutraceutical LLC", "address_1": "700 Spirit Of Saint Louis Blvd Ste I", "address_2": "N/A", "postal_code": "63005-1025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-1569-2014", "product_description": "CHIROTHIN Dietary Supplement, 2 Fl Oz (60 ml), OTC. Manufactured for ChiroNeutraceutical, 877-377-7636, Chesterfield, MO 63005.", "product_quantity": "12,948 Bottles", "reason_for_recall": "Marketed without an Approved NDA/ANDA; Product contains unapproved hHCG.", "recall_initiation_date": "20140820", "center_classification_date": "20140909", "termination_date": "20150616", "report_date": "20140917", "code_info": "Lot #: 072010-22, Exp: 12/2013;  Lot #: 072010-23, Exp:  01/2014; Lot #: 072010-25, Exp:  03/2014; Lot #: 072010-26, Exp:  04/2014; Lot #: 072010-27, Exp:  05/2014; Lot #: 072010-29, Exp:  07/2014; Lot #: 072010-30, Exp:  08/2014; Lot #: 072010-31, Exp:  09/2014; Lot #: 072010-33, Exp:  11/2014;  Lot #: 072010-34, Exp:  01/2015; Lot #: 072010-36, Exp:  02/2015; Lot #: 072010-39, Exp:  05/2015; Lot #: 072010-43, Exp: 06/2015; and Lot #: 072010-48, Exp: 10/2015."}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0128-2015", "product_description": "Quad mix, 30 mg/1 mg/10 mcg/0.15 mg/mL (papaverine, phentolamine mesylate, alprostadil, atropine) packaged in a clear glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "30 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 08042014@36, Exp 11/2/2014", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; CALCIUM CITRATE, Tablet, 950 mg (200 MG ELEMENTAL Ca) may be potentially mislabeled as     TRIMETHOBENZAMIDE HCL, Capsule, 300 mg, NDC 53489037601, Pedigree: AD21858_10, EXP: 5/1/2014.", "address_2": "", "product_quantity": "200 Tablets", "code_info": "CALCIUM CITRATE, Tablet, 950 mg (200 MG ELEMENTAL Ca) has the following code    Pedigree: AD21846_24, EXP: 5/1/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "CALCIUM CITRATE, Tablet, 950 mg (200 MG ELEMENTAL Ca), Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904506260", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-473-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0104-2015", "product_description": "Morphine sulfate (PF) 3 mg/mL injectable packaged in 30 mL or 60 mL syringes, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "40 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 07242014@28, Exp 10/22/2014", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: CALCIUM ACETATE, Capsule, 667 mg may be potentially mislabeled as one of the following drugs:   ZOLPIDEM TARTRATE, Tablet, 2.5 mg (1/2 of 5 mg), NDC 64679071401, Pedigree: AD28355_1, EXP: 5/8/2014;  acetaZOLAMIDE, Tablet, 250 mg, NDC 51672402301, Pedigree: AD62865_1, EXP: 5/23/2014;  ZINC GLUCONATE, Tablet, 50 mg, NDC 00904319160, Pedigree: W003028, EXP: 6/12/2014;  PROPRANO", "address_2": "", "product_quantity": "3600 Capsules", "code_info": "CALCIUM ACETATE, Capsule, 667 mg has the following codes:  Pedigree:AD30180_1, EXP: 5/8/2014;  Pedigree:AD62865_4, EXP: 5/23/2014;  Pedigree:W003045, EXP:6/12/2014;  Pedigree: AD52412_11, EXP: 5/17/2014;  Pedigree: AD54587_1, EXP: 5/21/2014;  Pedigree: AD62986_1, EXP: 5/23/2014;  Pedigree: AD73623_1, EXP: 5/30/2014;  Pedigree: W003469, EXP: 6/20/2014;  Pedigree: AD42592_1, EXP: 5/14/2014;  Pedigree: AD52778_10, EXP: 5/20/2014;  Pedigree: W003460, EXP: 6/20/2014;  Pedigree: AD49463_1, EXP: 5/16/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "CALCIUM ACETATE, Capsule, 667 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00054008826.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-794-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69494", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Puerto Rico, and U.S. Virgin Islands.", "recall_number": "D-0282-2015", "product_description": "5% Dextrose and 0.9% Sodium Chloride Injection, USP, 1000 mL container,  Rx Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045,  NDC 0409-7941-09.", "product_quantity": "340,272 bags", "reason_for_recall": "Lack of Assurance of Sterility: Potential of punctures through the overwrap and primary container which may result in IV bag leaks.", "recall_initiation_date": "20141014", "center_classification_date": "20141125", "termination_date": "20151228", "report_date": "20141203", "code_info": "Lot # 32-104-JT; Exp. 08/15  Lot # 34-136-JT; Exp. 10/15  Lot # 36-092-JT; Exp. 12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0091-2015", "product_description": "Hydromorphone HCl/bupivacaine (PF) 10 mg/7.5 mg/mL injection packaged in 30 mL or 60 mL syringes, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "40 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 08182014@45, Exp 9/17/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Dubai", "state": "N/A", "country": "United Arab Emirates", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69370", "recalling_firm": "Sun Pharma Global Inc.", "address_1": "P.O. Box 12850", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-0236-2015", "product_description": "Venlafaxine Hydrochloride Extended-Release Tablets, 37.5 mg, 30-count bottles and 90-count bottles, RX only, Manufactured for Sun Pharma Global Inc. Dubai, United Arab Emirates by Sun Pharmaceutical Industries Limited, Halol, India", "product_quantity": "68194", "reason_for_recall": "Failed Dissolution Specifications; 12 month stability time point", "recall_initiation_date": "20140926", "center_classification_date": "20141104", "termination_date": "20150506", "report_date": "20141112", "code_info": "Batch Number: JKM3855A  Mfg. Date: 06/25/2013  Exp. Date: 05/31/2015    Batch Number: JKM3855B  Mfg. Date: 06/25/2013  Exp. Date: 05/31/2015    Batch Number: JKM7265A  Mfg. Date: 12/25/2013  Exp. Date: 11/30/2015    Batch Number: JKM7265B  Mfg. Date: 12/25/2013  Exp. Date: 11/30/2015"}, {"status": "Terminated", "city": "Bedford", "state": "OH", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "67512", "recalling_firm": "Ben Venue Laboratories Inc", "address_1": "300 Northfield Rd", "address_2": "N/A", "postal_code": "44146", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide.", "recall_number": "D-1326-2014", "product_description": "Acetylcysteine Solution, USP, 10%, 30 mL vial, Rx only, Ben Venue Laboratories, Inc., Bedford, OH, NDC 0054-3025-02", "product_quantity": "5,131 vials", "reason_for_recall": "Presence of Particulate Matter: During a review of retain samples, the firm found a glass particulate in one lot of Acetylcysteine Solution", "recall_initiation_date": "20140214", "center_classification_date": "20140519", "termination_date": "20150629", "report_date": "20140528", "code_info": "2005479, Exp 03/14"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: SOTALOL HCL, Tablet, 160 mg may have potentially been mislabeled as the following drug:  DISULFIRAM, Tablet, 250 mg, NDC 64980017101, Pedigree: AD22609_1, EXP: 5/2/2014.", "address_2": "", "product_quantity": "101 Tablets", "code_info": "SOTALOL HCL, Tablet, 160 mg has the following codes:   Pedigree: AD22609_10, EXP: 4/30/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "SOTALOL HCL, Tablet, 160 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093106201.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-834-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Pomona", "address_1": "3201 Producer Way", "reason_for_recall": "CGMP Deviations: Active Pharmaceutical Ingredient (API) used for manufacture was stored in a non-GMP compliant warehouse at S.I.M.S., Italy.", "address_2": "", "product_quantity": "302,976 Bottles", "code_info": "Lot #: 3B251, Expiry: 02/16; Lot #: 3B250, Expiry: 02/16; Lot #: 3B251, Expiry: 02/16; Lot #: 3C252, Expiry: 03/16; Lot #: 3C253, Expiry: 03/16.", "center_classification_date": "20141223", "distribution_pattern": "U.S. Nationwide and Canada (Ontario).", "state": "CA", "product_description": "Eye Drops A.C. (Tetrahydrozoline HCl 0.05%, Zinc sulfate 0.25%), 0.5 FL OZ (15 mL) Bottles, Over the Counter.  Labeled: a) Astringent Redness Reliever, Distributed by Safeway Inc., P.O. Box 99, Pleasanton, CA 94566-0009, UPC: 3 21130 70067 8; b) Best Choice, Distributed By: Valu Merchandisers, Co., 5000 Kansas Ave, Kansas City, KS 66106, UPC: 0 70038 47010 6; c) EQUALINE, Distributed by Supervalu Inc., Eden Prairie, MN, UPC: 0 41163 25114 4; d) GOODSENSE, Manufactured By: KC Pharmaceuticals, Pomona, CA 91768, UPC: 1 80410 00018 7, NDC: 48879-010-07; e) H-E-B, Made for: H-E-B, San Antonio, TX 78204, UPC: 0 41220 86936 7; f) healthy accents, Distributed by: DZA Brands, LLC 2110 Executive Drive, Salisbury, NC 28147, UPC: 7 25439 93382 7; g) HyVee, Distributed By Hy-Vee, Inc., 5820 Westown Parkway, West Des Moines, IA 50266, UPC: 0 75450 29777 5; h) Kroger, Distributed by The Kroger Co., Cincinnati, Ohio 45202, UPC: 0 11110 38599 4; i) life, Imported for/Importe pour: SHOPPERS DRUG MART PHARMAPRIX., Toronto, M2J 4W8, by/par: Arrow OTC Inc., Mississauga, Ontario L5N 2B8, UPC: 0 57800 19617 4; j) LiveBetter, Distributed By Onpoint. Inc., 2 Paragon Drive, Montvale, NJ 07645, UPC: 0 41310 62041 0; k) meijer, Dist. by Meijer Distribution, Inc., 2929 Walker Ave NW, Grand Rapids, MI 49544, UPC: 0 41250 82918 8; l) Publix, Distributed by Publix Super Markets, Inc., 3300 Publix Corporate Parkway, Lakeland, FL 33811, UPC: 0 41415 01176 2; m) QUALITY CHOICE, Distributed by Quality Choice, Novi, MI 48376, UPC: 6 35515 99505 5; n) REDNESS RELIEF ASTRINGENT, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895, UPC: 0 50428 79686 3; o)Rexall, Manufactured for: Rexall Brands Corp., Mississauga, Ontario L4Z 1R9, Imported by: Arrow OTC Company, Mississauga, Ontario L5N 2B8, UPC: 7 71058 10159 8; p) Rexall, Fabrique pour: Rexall Brands Corp., Mississauga, Ontario L4Z 1R9, Importe par: Arrow OTC Company, Mississauga, Ontario L5N 2B8, UPC: 7 71058 10159 8; q) select brand, Distributed by: SELECT BRAND DISTRIBUTORS, Pine Bluff, AR 71603, UPC: 0 15127 00363 6; r) Smart sense, Distributed by: Kmart Corporation, Hoffman Estates, IL 60179, UPC: 7 20007 96092 2; s) TopCare, Distributed by Topco Associates LLC, 7711 Gross Point Road, Skokie, IL 60077, UPC: 0 36800 03640 6; t)WESTERN FAMILY, Distributed by Western Family Foods, Inc., P.O. Box 4057 Portland, OR 97208, UPC: 0 15400 04552 0.", "report_date": "20141231", "classification": "Class III", "openfda": {}, "recalling_firm": "K C Pharmaceuticals Inc", "recall_number": "D-0321-2015", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "69945", "termination_date": "20151026", "more_code_info": "", "recall_initiation_date": "20141204", "postal_code": "91768-3916", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "South Lyon", "address_1": "350 S Lafayette St", "reason_for_recall": "Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.", "address_2": "", "product_quantity": "2801 doses", "code_info": "All unexpired lots, manufactured and distributed between 07/01/2013 and 10/19/2013; including Lot #s: for both sizes: 08072013@26, 08282013@52, 09112013@31, 09162013@33, 10072013@33, 07242013@47, 08082013@42, 09172013@52, 10162013@35, 07242013@55, 07242013@56, 09122013@36, 09122013@35, 10042013@8, 10042013@9, 07262013@12, 07262013@13, 07262013@14, 07262013@16, 08082013@35, 08082013@41, 08152013@44, 08162013@21, 08292013@53, 08302013@24, 08302013@25, 08302013@35, 09062013@20, 09132013@26, 09132013@12, 09132013@13, 09202013@34, 09202013@35, 09202013@36, 09262013@24, 10092013@36, 10092013@39, 10102013@37, 10112013@34, 10162013@44, 10172013@26, 10172013@27", "center_classification_date": "20140110", "distribution_pattern": "Hospitals, clinics, physicians, and patients in the Michigan area only.", "state": "MI", "product_description": "Bevacizumab, (repackaged) in a) 0.11 mL and b) 0.06 mL, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI  48178", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Specialty Medicine Compounding Pharmacy", "recall_number": "D-412-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "66566", "termination_date": "20140922", "more_code_info": "", "recall_initiation_date": "20131019", "postal_code": "48178-1814", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "South Lyon", "address_1": "350 S Lafayette St", "reason_for_recall": "Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.", "address_2": "", "product_quantity": "5.5 mL", "code_info": "All unexpired lots, manufactured and distributed between 07/01/2013 and 10/19/2013; including Lot #: t10142013@30", "center_classification_date": "20140110", "distribution_pattern": "Hospitals, clinics, physicians, and patients in the Michigan area only.", "state": "MI", "product_description": "TROPICAMIDE* 1% OPHTHALMIC SOLUTION, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI 48178", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Specialty Medicine Compounding Pharmacy", "recall_number": "D-452-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "66566", "termination_date": "20140922", "more_code_info": "", "recall_initiation_date": "20131019", "postal_code": "48178-1814", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "South Lyon", "address_1": "350 S Lafayette St", "reason_for_recall": "Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.", "address_2": "", "product_quantity": "a) Injectable 600 mL; b) Topical 800 mL", "code_info": "All unexpired lots, manufactured and distributed between 07/01/2013 and 10/19/2013; including Lot #s: a) Injectable 09252013@10, 09302013@1, 10152013@5, ; b) Topical 09252013@11, 09302013@3, 10152013@7", "center_classification_date": "20140110", "distribution_pattern": "Hospitals, clinics, physicians, and patients in the Michigan area only.", "state": "MI", "product_description": "DT- Tranexamic Acid* 2 gm/100 mL Drug Study -IV 100 mL injectable, DT-, DT-Tranexamic Acid* 2 gm/100 mL-Drug Study-Topical 100 mL Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI  48178", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Specialty Medicine Compounding Pharmacy", "recall_number": "D-459-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "66566", "termination_date": "20140922", "more_code_info": "", "recall_initiation_date": "20131019", "postal_code": "48178-1814", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; SERTRALINE HCL Tablet, 50 mg may be potentially mislabeled as    NORTRIPTYLINE HCL, Capsule, 10 mg, NDC 00093081001, Pedigree: AD70585_4, EXP: 5/29/2014;  guaiFENesin ER, Tablet, 600 mg, NDC 63824000834, Pedigree: W003574, EXP: 6/24/2014;  OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1,110 mg, NDC 11523726503, Pedigree: AD46300_17, EXP: 5/15/2014;  CHOLECALCIFEROL, Tablet,", "address_2": "", "product_quantity": "500 Tablets", "code_info": "SERTRALINE HCL Tablet, 50 mg has the following codes    Pedigree: AD70585_7, EXP: 5/29/2014;  Pedigree: W003575, EXP: 6/24/2014;  Pedigree: AD46426_1, EXP: 5/15/2014;  Pedigree: AD30993_14, EXP: 5/9/2014;  Pedigree: W003033, EXP: 6/12/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "SERTRALINE HCL Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 16714061204", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-523-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Pomona", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["M018"], "brand_name": ["GOOD NEIGHBOR PHARMACY EYE DROPS", "SUNMARK EYE DROPS ADVANCED MOISTURIZER/LUBRICANT"], "generic_name": ["DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HYDROCHLORIDE", "DEXTRAN, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE"], "manufacturer_name": ["AmerisourceBergen Drug Corporation", "Strategic Sourcing Services LLC"], "product_ndc": ["24385-077", "49348-697"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["DEXTRAN 70", "POLYETHYLENE GLYCOL 400", "POVIDONE", "TETRAHYDROZOLINE HYDROCHLORIDE"], "rxcui": ["996202"], "spl_id": ["0cfa2cc7-bb83-af55-e063-6394a90a28f0", "0d2942e7-fe3a-4dd4-e063-6394a90a020f"], "spl_set_id": ["af71f013-108e-4a37-8f5f-674bf95fa4e8", "0daa4e39-0447-44b6-a7d7-370b12bf9451"], "package_ndc": ["24385-077-05", "49348-697-29", "48879-007-07", "62011-0104-1"], "is_original_packager": [true], "upc": ["0087701106637", "321130700647", "070038470090", "041163253926", "183164000229", "614299396258", "087701106637", "180410000194", "041220891375", "052569134740", "725439933834", "075450297782", "011110385987", "057800156406", "041310620434", "095072012518", "041250829171", "070253966835", "041415067769", "015127003643", "010939168337", "036800036413", "015400032810"], "nui": ["N0000184175", "N0000009361", "N0000010288"], "pharm_class_epc": ["Plasma Volume Expander [EPC]"], "pharm_class_pe": ["Increased Intravascular Volume [PE]"], "pharm_class_moa": ["Osmotic Activity [MoA]"], "unii": ["7SA290YK68", "B697894SGQ", "FZ989GH94E", "0YZT43HS7D"]}, "product_type": "Drugs", "event_id": "69945", "recalling_firm": "K C Pharmaceuticals Inc", "address_1": "3201 Producer Way", "address_2": "", "postal_code": "91768-3916", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide and Canada (Ontario).", "recall_number": "D-0323-2015", "product_description": "Eye Drops Advanced Relief (Dextran 70 0.1%, Polyethylene glycol 400 1%, Povidone 1%, Tetrahydrozoline HCl 0.05%), 0.5 FL OZ (15 mL) Bottles, Over the Counter.  Labeled: a) Advanced Relief, Distributed by Safeway Inc., P.O.Box 99, Pleasanton, CA 94566-0009, UPC: 3 21130 70064 7; b) Best Choice, Distributed By: Valu Mercahndisers, Co., 5000 Kansas Ave, Kansas City, KS 66106, UPC: 0 70038 47009 0; c) EQUALINE, Distributed By Supervalu Inc., Eden Prairie, MN 55344, UPC: 0 41163 25392 6; d) equate, Manufactured for/Fabrique pour: Wal-Mart Canada Corp, 1940 Argentia Rd, Mississauga Ontario L5N 1P9, Imported by/ Importe par: Arrow OTC Company, Mississauga, Ontario L5N 2B8, UPC: 1 83164 00022 9; e) exchange select, Manufactured For: Your Military Exchanges By: KC Pharmaceuticals, Inc., Pomona, CA 91768, UPC: 6 14299 39625 8; f) GOOD NEIGHBOR PHARMACY, Distributed By AmerisourceBergen 1300 Morris Drive, Chesterbrook, PA 19087, UPC: 0 87701 10663 7, NDC: 24385-077-05; g) GOODSENSE, Manufactured By: KC Pharmaceuticals, Pomona, CA 91768, UPC: 1 80410 00019 4, NDC: 48879-007-07; h) H-E-B, Made for H-E-B, San Antonio, TX 78204, UPC: 0 41220 89137 5; i) Health Mart, Distributed by McKesson, One Post Street, San Francisco, CA 94104, UPC: 0 52569 13474 0, NDC: 62011-0104-1; j) healthy accents, Distributed by: DZA Brands, LLC, 2110 Executive Drive, Salisbury, NC 28147, NDC: 7 25439 93383 4; k) HyVee, Distributed By Hy-Vee, Inc., 5820 Westown Parkway, West Des Moines, IA 50266, UPC: 0 75450 29778 2; l) Kroger, Distributed by The Kroger Co., Ohio 45202, UPC: 0 11110 38598 7; m) life, Imported for/ Importe pour: SHOPPERS DRUG MART PHARMAPRIX, Toronto, M2J 4W8, by/par: Arrow OTC Inc., Mississauga, Ontario L5N 2B8, UPC: 0 57800 15640 6; n) LiveBetter, Distributed by Onpoint, Inc., 2 Paragon Drive, Montvale, NJ 07645, UPC: 0 41310 62043 4; o) Medic's Choice, KC Pharmaceuticals, Inc., Pomona, CA 91768, UPC: 0 95072 01251 8, NDC: 055654-025; p) meijer, Dist. By Meijer Distribution, Inc., 2929 Walker Ave NW, Grand Rapids, MI 49544, UPC: 0 41250 82917 1; q) Our Family, Distributed by NASH FINCH COMPANY, NFC Brands, 7600 France Ave S, MPLS 55435, UPC: 0 70253 96683 5; r) Publix, Distributed by Publix Super Markets, Inc., 3300 Publix Corporate Parkway, Lakeland, FL 33811, UPC: 0 41415 06776 9; s) Rexall, Manufactured for: Rexall Brands Corp., Mississauga, Ontario L5N 2B8, Imported by: Arrow OTC Company, Mississauga, Ontario L5N 2B8, UPC: 7 71058 10462 8; t) Rexall, Fabrique pour: Rexall Brands Corp., Mississauga, Ontario L5N 2B8, Importe par: Arrow OTC Company, Mississauga, Ontario L5N 2B8, UPC: 7 71058 10462 8; u) select brand, Distributed by: SELECT BRAND DISTRIBUTORS, Pine Bluff, AR 71603, UPC: 0 15127 00364 3; v) sunmark, Distributed By McKesson, One Post Street, San Francisco, CA 94104, UPC: 0 10939 16833 7, NDC: 49348-697-29; w) TopCare, Distributed by Topco Associates LLC, 7711 Gross Point Road, Skokie, IL 60077, UPC: 0 36800 03641 3; x) WESTERN FAMILY, Distributed by Western Family Foods, Imc., P.O.Box 4057, Portland OR 97208, UPC: 0 15400 03281 0.", "product_quantity": "427,512 Bottles", "reason_for_recall": "CGMP Deviations: Active Pharmaceutical Ingredient (API) used for manufacture was stored in a non-GMP compliant warehouse at S.I.M.S., Italy.", "recall_initiation_date": "20141204", "center_classification_date": "20141223", "termination_date": "20151026", "report_date": "20141231", "code_info": "Lot #: 3A350, Expiry: 01/16; Lot #: 3B351, Expiry: 02/16; Lot #: 3C352, Expiry: 03/16; Lot #: 3C353, Expiry: 03/16; Lot #: 3C354, Expiry: 03/16.", "more_code_info": ""}, {"status": "Terminated", "city": "Morrisville", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68917", "recalling_firm": "Unit Dose Solutions Inc", "address_1": "860 Aviation Pkwy Ste 400A", "address_2": "N/A", "postal_code": "27560-7395", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "PA", "recall_number": "D-0017-2015", "product_description": "Atorvastatin Calcium 40 MG Tablet, MFG: Apotex NDC# 6050525808", "product_quantity": "1,177 packets", "reason_for_recall": "Presence of Foreign Tablets/Capsules:179 doses of Valacyclovir HCl 500 mg tablets were repacked in unit dose packslabeled as Atorvastatin Calcium", "recall_initiation_date": "20140602", "center_classification_date": "20141010", "termination_date": "20141016", "report_date": "20141022", "code_info": "Lot 204751 Exp. 04/15"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0136-2015", "product_description": "Sodium tetradecyl sulfate 5% (PF) injectable packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "270 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 08062014@32, Exp 9/5/2014; 08072014@62, Exp 9/6/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68941", "recalling_firm": "Wockhardt Usa Inc.", "address_1": "20 Waterview Blvd., Suite 3", "address_2": "", "postal_code": "07054", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1541-2014", "product_description": "Wockhardt Metoprolol Succinate Extended-Release Tablets, USP 200 mg, a) 100-count bottle (NDC 64679-737-02), b) 500-count bottle (NDC 64679-737-03)  Rx only, Manufactured by: Wockhardt Limited Mumbai, India Distributed by: Wockhardt USA LLC 20 Waterview Boulevard. Parsippany, NJ 07054 USA", "product_quantity": "11,661 HDPE bottles", "reason_for_recall": "Failed Dissolution Specifications: Dissolution failures found during testing of control samples at the four hour time point.", "recall_initiation_date": "20140724", "center_classification_date": "20140818", "termination_date": "20151120", "report_date": "20140827", "code_info": "Lot # a) LN11005, Exp 04/15; LN11006; Exp 04/15; b) LN10979; Exp. 04/15,  LN10980; Exp. 04/15", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: BROMOCRIPTINE MESYLATE, Tablet, 2.5 mg may have potentially been mislabeled as one of the following drugs:  BENAZEPRIL HCL, Tablet, 40 mg, NDC 65162075410, Pedigree: AD68010_1, EXP: 5/28/2014;  THIORIDAZINE HCL, Tablet, 50 mg, NDC 00378061601, Pedigree: AD73525_28, EXP: 5/30/2014.", "address_2": "", "product_quantity": "63 Tablets", "code_info": "BROMOCRIPTINE MESYLATE, Tablet, 2.5 mg has the following codes:   Pedigree: AD68010_4, EXP: 5/28/2014;  Pedigree: AD73525_40, EXP: 5/30/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "BROMOCRIPTINE MESYLATE, Tablet, 2.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00574010603.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-954-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0096-2015", "product_description": "Lidocaine (PF) 1% injectable packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "20 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 08152014@33, Exp 9/14/2014", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; guaiFENesin ER, Tablet, 600 mg may be potentially mislabeled as    PRENATAL MULTIVITAMIN/ MULTIMINERAL, Tablet, NDC 51991056601, Pedigree: AD62829_18, EXP: 5/24/2014;  guaiFENesin ER, Tablet, 600 mg, NDC 63824000834, Pedigree: AD62834_4, EXP: 5/24/2014;  diphenhydrAMINE HCl, Tablet, 25 mg, NDC 00904555159, Pedigree: W003513, EXP: 6/21/2014;  DOCUSATE SODIUM, Capsule, 250 mg,", "address_2": "", "product_quantity": "480 Tablets", "code_info": "guaiFENesin ER, Tablet, 600 mg has the following codes    Pedigree: AD62834_4, EXP: 5/24/2014;  Pedigree: AD62834_7, EXP: 5/24/2014;  Pedigree: W003514, EXP: 6/21/2014;  Pedigree: W003574, EXP: 6/24/2014;  Pedigree: W003850, EXP: 6/27/2014;  Pedigree: W003931, EXP: 6/28/2014;  Pedigree: AD46429_1, EXP: 5/15/2014;  Pedigree: AD73592_1, EXP: 5/31/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "guaiFENesin ER Tablet, 600 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 63824000834", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-683-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; COENZYME Q-10, Capsule, 30 mg may be potentially mislabeled as    PANCRELIPASE DR, Capsule, 12000 /38000 /60000 USP units, NDC 00032121201, Pedigree: W002819, EXP: 6/7/2014.", "address_2": "", "product_quantity": "60 Capsules", "code_info": "COENZYME Q-10, Capsule, 30 mg has the following code    Pedigree: W002814, EXP: 6/7/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "COENZYME Q-10, Capsule, 30 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904501546", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-468-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; CILOSTAZOL Tablet, 100 mg may be potentially mislabeled as    DUTASTERIDE, Capsule, 0.5 mg, NDC 00173071204, Pedigree: AD65475_1, EXP: 5/28/2014.", "address_2": "", "product_quantity": "60 Tablets", "code_info": "CILOSTAZOL Tablet, 100 mg has the following code    Pedigree: AD65475_4, EXP: 5/28/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "CILOSTAZOL Tablet, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 60505252201", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-660-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; PRAMIPEXOLE DI-HCL, Tablet, 1 mg may be potentially mislabel as    MISOPROSTOL, Tablet, 200 mcg, NDC 59762500801, Pedigree: W003117, EXP: 6/13/2014.", "address_2": "", "product_quantity": "90 Tablets", "code_info": "PRAMIPEXOLE DI-HCL Tablet, 1 mg has the following code    Pedigree: W003150, EXP: 6/13/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PRAMIPEXOLE DI-HCL Tablet, 1 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 16714058701", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-522-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Brookfield", "address_1": "19035 W. Capitol Dr", "reason_for_recall": "Incorrect/Undeclared Excipients: Specific drug products were compounded with an incorrect solvent.", "address_2": "Suite 105", "product_quantity": "6000 mL", "code_info": "Lot # / Beyond Use Date:  04282014@11 / BUD 05/28/14; 04212014@4 / BUD 05/21/2014", "center_classification_date": "20140703", "distribution_pattern": "WI only", "state": "WI", "product_description": "Mometasone 0.6 mg /60 mL Irrigation solution, 4000 mL bottle, Rx only, MD Custom Rx, 19035 W. Capitol Dr., Ste. 105, Brookfield, WI  53045", "report_date": "20140709", "classification": "Class II", "openfda": {}, "recalling_firm": "Brookfield Prescription Center Inc. dba MD Custom Rx", "recall_number": "D-1416-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "68616", "termination_date": "20150522", "more_code_info": "", "recall_initiation_date": "20140530", "postal_code": "53045", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: PYRIDOXINE HCL, Tablet, 25 mg may have potentially been mislabeled as the following drug:  TORSEMIDE, Tablet, 10 mg, NDC 50111091601, Pedigree: AD30197_25, EXP: 5/9/2014.", "address_2": "", "product_quantity": "102 Tablets", "code_info": "PYRIDOXINE HCL, Tablet, 25 mg has the following codes:   Pedigree: AD30197_28, EXP: 5/9/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PYRIDOXINE HCL, Tablet, 25 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536440601.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-940-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Camarillo", "address_1": "5187 Camino Ruiz", "reason_for_recall": "Presence of Foreign Substance; some bottles may contain debris that was swept up during cleaning", "address_2": "", "product_quantity": "6,042 bottles", "code_info": "Lot Number GS003057. Exp Date 03/2016.", "center_classification_date": "20140602", "distribution_pattern": "Nationwide", "state": "CA", "product_description": "LOSARTAN POTASSIUM Tablets, USP, 50 mg, 30 count bottles, Rx only, Manufactured by Arrow Pharm (Malta) Ltd., Bizebbugia, Malta, Packaged by GSMS, Inc. Camarillo, CA --- NDC 60429-317-30", "report_date": "20140611", "classification": "Class II", "openfda": {}, "recalling_firm": "Golden State Medical Supply Inc.", "recall_number": "D-1357-2014", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "68009", "termination_date": "20140709", "more_code_info": "", "recall_initiation_date": "20140414", "postal_code": "93012-8601", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Deltona", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "67471", "recalling_firm": "MyNicNaxs, Inc.", "address_1": "1012 Alpine Dr", "address_2": "N/A", "postal_code": "32725-7204", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1380-2014", "product_description": "Meizitang Strong Version Botanical Slimming, Soft Gel Capsules, 650 mg, supplied in 30 count bottles, distributed by MyNicKnaxs, LLC, Deltona, FL", "product_quantity": "unknown", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceutical ingredients: N-desmethylsibutramine, benzylsibutramine, and sibutramine", "recall_initiation_date": "20140124", "center_classification_date": "20140612", "termination_date": "20191002", "report_date": "20140618", "code_info": "ALL LOTS"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: PERPHENAZINE, Tablet, 16 mg may have potentially been mislabeled as one of the following drugs:  MELATONIN, Tablet, 1 mg, NDC 47469000466, Pedigree: AD46257_19, EXP: 5/15/2014;  LITHIUM CARBONATE ER, Tablet, 450 mg, NDC 00054002025, Pedigree: AD60272_25, EXP: 5/22/2014;  MONTELUKAST SODIUM, CHEW Tablet, 4 mg, NDC 00006071131, Pedigree: AD76639_11, EXP: 5/31/2014.", "address_2": "", "product_quantity": "2400 Tablets", "code_info": "PERPHENAZINE, Tablet, 16 mg has the following codes:   Pedigree: AD46265_49, EXP: 5/15/2014;  Pedigree: AD60272_82, EXP: 5/22/2014;  Pedigree: W002612, EXP: 6/4/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PERPHENAZINE, Tablet, 16 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00603506321.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-989-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Zurich", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075154"], "brand_name": ["MIDAZOLAM"], "generic_name": ["MIDAZOLAM HYDROCHLORIDE"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "product_ndc": ["63323-411", "63323-412"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["MIDAZOLAM HYDROCHLORIDE"], "rxcui": ["311700", "311702"], "spl_id": ["9814447b-a93e-42ad-b57e-5db0a5b7f552"], "spl_set_id": ["a91ce254-14a3-4cbf-8ab8-5da252aa3fdc"], "package_ndc": ["63323-411-22", "63323-411-27", "63323-411-15", "63323-411-12", "63323-411-18", "63323-411-25", "63323-411-13", "63323-411-10", "63323-412-18", "63323-412-25", "63323-412-03", "63323-412-02", "63323-412-06", "63323-412-05", "63323-412-13", "63323-412-10"], "is_original_packager": [true], "upc": ["0363323411183", "0363323411138", "0363323412135", "0363323411220", "0363323412180", "0363323412036", "0363323411152"], "unii": ["W7TTW573JJ"]}, "product_type": "Drugs", "event_id": "63451", "recalling_firm": "Fresenius Kabi USA, LLC", "address_1": "3 Corporate Dr", "address_2": "N/A", "postal_code": "60047-8930", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide Including Puerto Rico", "recall_number": "D-0295-2015", "product_description": "MIDAZOLAM HYDROCHLORIDE INJECTION, 5 mg/1 mL, C-IV, For IM or IV Use, 2 mL Vials, Rx only.  APP Pharmaceuticals, LLC. Schaumburg, IL 60173. NDC: 63323-412-25.", "product_quantity": "101,200 Vials", "reason_for_recall": "Lack of Assurance of Sterility: Glass vials may have finish fractures and glass particles.", "recall_initiation_date": "20120927", "center_classification_date": "20141210", "termination_date": "20141212", "report_date": "20141217", "code_info": "Lot 6003827, Exp. Date 04/2015"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; QUETIAPINE FUMARATE Tablet, 12.5 mg (1/2 of 25 mg) may be potentially mislabeled as    SIMVASTATIN, Tablet, 40 mg, NDC 00093715598, Pedigree: AD22845_4, EXP: 5/2/2014.", "address_2": "", "product_quantity": "200 Tablets", "code_info": "QUETIAPINE FUMARATE, Tablet, 12.5 mg (1/2 of 25 mg) has the following code    Pedigree: AD21790_79, EXP: 5/1/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "QUETIAPINE FUMARATE Tablet, 12.5 mg (1/2 of 25 mg), Rx only, Distributed by: AidaPak Service, LLC, NDC 47335090288", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-575-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; DOCUSATE SODIUM, Capsule, 250 mg may be potentially mislabeled as    ATROPINE SULFATE/DIPHENOXYLATE HCL, Tablet, 0.025 mg/2.5 mg, NDC 00378041501, Pedigree: AD65475_13, EXP: 5/28/2014;  VALSARTAN, Tablet, 80 mg, NDC 00078035834, Pedigree: AD68025_1, EXP: 5/28/2014;  PANTOPRAZOLE SODIUM DR, Tablet, 40 mg, NDC 64679043402, Pedigree: AD37063_10, EXP: 5/13/2014;  DOCUSATE SODIUM", "address_2": "", "product_quantity": "4,318 Capsules", "code_info": "DOCUSATE SODIUM, Capsule, 250 mg has the following codes    Pedigree: AD68028_1, EXP: 5/28/2014;  Pedigree: AD68022_1, EXP: 5/28/2014;  Pedigree: AD37072_1, EXP: 5/13/2014;  Pedigree: AD37072_4, EXP: 5/13/2014;  Pedigree: AD56924_1, EXP: 5/21/2014;  Pedigree: W003671, EXP: 6/25/2014;  Pedigree: W002920, EXP: 6/10/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "DOCUSATE SODIUM, Capsule, 250 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904789159", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-491-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: METOPROLOL TARTRATE, Tablet, 25 mg may have potentially been mislabeled as the following drug:  DOCUSATE SODIUM, Capsule, 250 mg, NDC 00536375710, Pedigree: AD76675_1, EXP: 6/3/2014.", "address_2": "", "product_quantity": "200 Tablets", "code_info": "METOPROLOL TARTRATE, Tablet, 25 mg has the following codes:   Pedigree: W002535, EXP: 6/3/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "METOPROLOL TARTRATE, Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378001801.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-888-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; ASCORBIC ACID Tablet, 500 mg may be potentially mislabeled as    FEBUXOSTAT, Tablet, 40 mg, NDC 64764091830, Pedigree: AD23082_16, EXP: 11/1/2013.", "address_2": "", "product_quantity": "300 Tablets", "code_info": "ASCORBIC ACID Tablet, 500 mg has the following code    Pedigree: AD23082_19, EXP: 5/6/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ASCORBIC ACID Tablet, 500 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 60258014101", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-652-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; BENAZEPRIL HCL Tablet, 40 mg may be potentially mislabeled as    NEFAZODONE HCL, Tablet, 200 mg, NDC 00093102506, Pedigree: AD46414_44, EXP: 5/16/2014;  guaiFENesin ER, Tablet, 600 mg, NDC 63824000834, Pedigree: W003931, EXP: 6/28/2014;  CALCIUM ACETATE, Capsule, 667 mg, NDC 00054008826, Pedigree: AD42592_1, EXP: 5/14/2014;  ACETAMINOPHEN/ ASPIRIN/ CAFFEINE, Tablet, 250 mg/25", "address_2": "", "product_quantity": "799 Tablets", "code_info": "BENAZEPRIL HCL Tablet, 40 mg has the following codes    Pedigree: AD49423_1, EXP: 5/16/2014;  Pedigree: W003918, EXP: 6/28/2014;  Pedigree: AD32757_7, EXP: 5/13/2014;  Pedigree: AD68010_1, EXP: 5/28/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "BENAZEPRIL HCL Tablet, 40 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 65162075410", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-713-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0129-2015", "product_description": "Quad mix, 30 mg/1 mg/20 mcg/0.15 mg/mL (papaverine, phentolamine mesylate, alprostadil, atropine) injectable packaged in a clear glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "30 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 06052014@16, Exp 9/15/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Waltham", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67995", "recalling_firm": "Fresenius Medical Care Holdings, Inc.", "address_1": "920 Winter St", "address_2": "N/A", "postal_code": "02451-1521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "PA", "recall_number": "D-1343-2014", "product_description": "phosLo (calcium acetate) GelCaps, 667 mg, 200-count bottle, Rx only, Manufactured for Fresenius Medical Care North America, Waltham, MA 02451, NDC 0781-2081-02", "product_quantity": "14,496 bottles", "reason_for_recall": "Cross Contamination with Other Products: Potential for contaminant on the cotton packaging inside the bottle.  Chemical analysis of the contaminant found on the cotton was identified as a formulation of 4% Trimipramine methanesulfonate - a tricyclic antidepressant..", "recall_initiation_date": "20140414", "center_classification_date": "20140521", "termination_date": "20150813", "report_date": "20140528", "code_info": "Lot # 13064, 13065, 13066; Exp. 08/18"}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0173-2015", "product_description": "ALPROSTADIL, 10 mcg/mL, injectable, 1.7 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070.", "product_quantity": "5 mL", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #: 20140913@10, discard date 10/28/2014"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; METOPROLOL TARTRATE Tablet, 12.5 mg (1/2 of 25 mg) may be potentially mislabeled as    DOCUSATE SODIUM, Capsule, 250 mg, NDC 00904789159, Pedigree: AD68022_1, EXP: 5/28/2014;  METOPROLOL TARTRATE, Tablet, 12.5 mg (1/2 of 25 mg), NDC 57664050652, Pedigree: AD68010_14, EXP: 5/28/2014.", "address_2": "", "product_quantity": "402 Tablets", "code_info": "METOPROLOL TARTRATE, Tablet, 12.5 mg (1/2 of 25 mg) has the following codes    Pedigree: AD68010_14, EXP: 5/28/2014;  Pedigree: AD68010_17, EXP: 5/28/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "METOPROLOL TARTRATE Tablet, 12.5 mg (1/2 of 25 mg), Rx only, Distributed by: AidaPak Service, LLC,  NDC 57664050652", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-628-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; CALCIUM CITRATE, Tablet, 950 mg (200 mg Elemental Calcium) may be potentially mislabeled as     LITHIUM CARBONATE ER, Tablet, 450 mg, NDC 00054002025, Pedigree: AD46265_10, EXP: 5/15/2014.", "address_2": "", "product_quantity": "200 Tablets", "code_info": "CALCIUM CITRATE, Tablet, 950 mg (200 mg Elemental Calcium) has the following code    Pedigree: AD46257_43, EXP: 5/15/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "CALCIUM CITRATE, Tablet, 950 mg (200 mg Elemental Calcium), Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904506260", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-474-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: ATOMOXETINE HCL, Capsule, 40 mg may be potentially mis-labeled as OLANZAPINE, Tablet, 7.5 mg, NDC 60505311203, Pedigree: AD21790_76, EXP: 5/1/2014;  ARIPiprazole, Tablet, 2 mg, NDC 59148000613, Pedigree: AD46265_19, EXP: 5/15/2014;  OLANZapine, Tablet, 7.5 mg, NDC 55111016530, Pedigree: AD60272_79, EXP: 5/22/2014;  OLANZapine, Tablet, 7.5 mg, NDC 55111016530, Pedigree:  AD73", "address_2": "", "product_quantity": "180 Capsules", "code_info": "ATOMOXETINE HCL, Capsule, 40 mg has the following codes:    Pedigree: AD21790_82, EXP: 5/1/2014;   Pedigree: AD46265_52, EXP: 5/15/2014;  Pedigree: AD60272_89, EXP: 5/22/2014;  Pedigree: AD73525_67, EXP: 5/30/2014;  Pedigree: W003014, EXP: 6/11/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ATOMOXETINE HCL, Capsule, 40 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00002322930.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-765-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Sanford", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "67420", "recalling_firm": "Hill Dermaceuticals, Inc.", "address_1": "2650 S Mellonville Ave", "address_2": "N/A", "postal_code": "32773-9311", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1181-2014", "product_description": "SETON PHARMACEUTICALS Fluocinolone Acetonide 0.01%  Oil EAR DROPS, 20 ml, Rx only Manufactured by: Hill Dermaceuticals, Inc. For:  Seton Pharmaceuticals NDC 13925-508-20", "product_quantity": "13,591 bottles", "reason_for_recall": "Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.", "recall_initiation_date": "20140131", "center_classification_date": "20140324", "termination_date": "20150203", "report_date": "20140402", "code_info": "13F017B exp. 12/14, 13F020B exp 12/14"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: SACCHAROMYCES BOULARDII LYO, Capsule, 250 mg may have potentially been mislabeled as one of the following drugs:  PREGABALIN, Capsule, 200 mg, NDC 00071101768, Pedigree: AD21787_1, EXP: 5/1/2014;  HYOSCYAMINE SULFATE SL, Tablet, 0.125 mg, NDC 76439030910, Pedigree: AD54501_1, EXP: 5/21/2014;  VARENICLINE, Tablet, 0.5 mg, NDC 00069046856, Pedigree: W003083, EXP: 6/12/2014;  L", "address_2": "", "product_quantity": "2024 Capsules", "code_info": "SACCHAROMYCES BOULARDII LYO, Capsule, 250 mg has the following codes:   Pedigree: AD21859_1, EXP: 10/31/2013;  Pedigree: AD54586_1, EXP: 5/21/2014;  Pedigree: W003030, EXP: 6/12/2014;  Pedigree: W003866, EXP: 6/27/2014;  Pedigree: AD37063_7, EXP: 5/13/2014;  Pedigree: W002917, EXP: 6/10/2014;  Pedigree: AD54586_4, EXP: 5/21/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "SACCHAROMYCES BOULARDII LYO, Capsule, 250 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00414200007.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-911-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Nashville", "address_1": "245B Great Circle Road", "reason_for_recall": "CGMP Deviation: Discoloration; Product fails specification for appearance/color.  A complaint was received regarding an abnormal appearance of children's ibuprofen suspension.", "address_2": "", "product_quantity": "3764 cups", "code_info": "600709, Use by:  04/14; 598148, Use by 04/14; 567904, Use by 01/14; 606466, Use by 05/14", "center_classification_date": "20140204", "distribution_pattern": "GA, KY, TN", "state": "TN", "product_description": "CHILDREN'S IBUPROFEN, ORAL SUSPENSION, 200 mg/10mL cup BERRY FLAVOR, ALCOHOL FREE, MFG: ACTAVIS, PGK BY SAFECOR Columbus, OH", "report_date": "20140212", "classification": "Class II", "openfda": {}, "recalling_firm": "Central Shared Services dba Parallon", "recall_number": "D-1062-2014", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "66313", "termination_date": "20140204", "more_code_info": "", "recall_initiation_date": "20130823", "postal_code": "37228", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Clifton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68891", "recalling_firm": "SST Corporation", "address_1": "635 Brighton Rd", "address_2": "N/A", "postal_code": "07012-1027", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "CA", "recall_number": "D-1517-2014", "product_description": "Tetrahydrozoline HCL, 16 kg drum.  Societa Italiana Medicinali Scandicci (S.I.M.S.), Made in Italy. NDC 12660-0048 CAS #522-48-5", "product_quantity": "1 Drum", "reason_for_recall": "CGMP Deviations; Stored/dispensed in a non-GMP compliant warehouse at S.I.M.S., Italy.", "recall_initiation_date": "20140717", "center_classification_date": "20140806", "termination_date": "20160804", "report_date": "20140813", "code_info": "Lot: 168.862, Expiry: 6/2017"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; PRENATAL MULTIVITAMIN/MULTIMINERAL, Tablet may be potentially mislabeled as    RILUZOLE, Tablet, 50 mg, NDC 00075770060, Pedigree: AD62992_11, EXP: 5/23/2014;  ASPIRIN, Chew Tablet, 81 mg, NDC 00536329736, Pedigree: W003093, EXP: 6/13/2014;  NIACIN TR, Capsule, 250 mg, NDC 00904062960, Pedigree: W003478, EXP: 6/20/2014;  PRENATAL MULTIVITAMIN/MULTIMINERAL, Tablet, NDC 009045", "address_2": "", "product_quantity": "1,501 Tablets", "code_info": "PRENATAL MULTIVITAMIN/MULTIMINERAL, Tablet has the following codes    Pedigree: AD62986_22, EXP: 5/23/2014;  Pedigree: W003098, EXP: 6/13/2014;  Pedigree: W003479, EXP: 6/20/2014;  Pedigree: W003480, EXP: 6/20/2014;  Pedigree: AD52993_13, EXP: 5/20/2014;  Pedigree: AD60428_7, EXP: 5/22/2014;  Pedigree: AD73652_16, EXP: 5/30/2014;  Pedigree: W003706, 6/25/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PRENATAL MULTIVITAMIN/MULTIMINERAL, Tablet, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904531360", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-478-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: chlordiazePOXIDE HCl, Capsule, 25 mg may have potentially been mislabeled as one of the following drugs:  FLECAINIDE ACETATE, Tablet, 50 mg, NDC 65162064110, Pedigree: AD46414_16, EXP: 5/16/2014;  CALCIUM ACETATE, Capsule, 667 mg, NDC 00054008826, Pedigree: AD49463_1, EXP: 5/16/2014;  LACTOBACILLUS GG, Capsule, 0 mg, NDC 49100036374, Pedigree: W003173, EXP: 6/13/2014.", "address_2": "", "product_quantity": "1,101 Capsules", "code_info": "chlordiazePOXIDE HCl, Capsule, 25 mg has the following codes:   Pedigree: AD46333_4, EXP: 5/16/2014;  Pedigree: AD49426_1, EXP: 5/16/2014;  Pedigree: W003194, EXP: 6/13/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "chlordiazePOXIDE HCl, Capsule, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00555015902.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-950-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; SIMVASTATIN Tablet, 20 mg may be potentially mislabeled as    VITAMIN B COMPLEX WITH C/FOLIC ACID, Tablet, NDC 60258016001, Pedigree: W003591, EXP: 6/24/2014.", "address_2": "", "product_quantity": "1,000 Tablets", "code_info": "SIMVASTATIN, Tablet, 20 mg has the following code    Pedigree: W003580, EXP: 6/24/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "SIMVASTATIN Tablet, 20 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 16714068303", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-524-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; traZODone HCl Tablet, 50 mg may be potentially mislabeled as    DEXAMETHASONE, Tablet, 1 mg, NDC 00054418125, Pedigree: AD37088_1, EXP: 5/9/2014;  DOCUSATE SODIUM, Capsule, 250 mg, NDC 00536375701, Pedigree: AD54498_4, EXP: 5/20/2014;  guanFACINE HCl, Tablet, 1 mg, NDC 00591044401, Pedigree: AD39611_1, EXP: 4/30/2014.", "address_2": "", "product_quantity": "400 Tablets", "code_info": "traZODone HCl, Tablet, 50 mg has the following codes    Pedigree: AD37088_4, EXP: 5/9/2014;  Pedigree: AD54562_1, EXP: 5/20/2014;  Pedigree: AD39611_4, EXP: 5/14/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "traZODone HCl Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 50111043301", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-592-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup:quiNIDine SULFATE, Tablet, 200 mg may have potentially been mislabeled as the following drug:   QUINAPRIL, Tablet, 40 mg, NDC 31722027090, Pedigree: AD52778_76, EXP: 5/21/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "quiNIDine SULFATE, Tablet, 200 mg has the following codes:   Pedigree: AD52778_79, EXP:  5/21/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "quiNIDine SULFATE, Tablet, 200 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591543801.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-975-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; PARoxetine HCl, Tablet, 10 mg may be potentially mislabeled as    PANTOPRAZOLE SODIUM DR, Tablet, 20 mg, NDC 62175018046, Pedigree: AD52778_64, EXP: 5/20/2014.", "address_2": "", "product_quantity": "30 Tablets", "code_info": "PARoxetine HCl, Tablet, 10 mg has the following code    Pedigree: AD52778_67, EXP: 5/20/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PARoxetine HCl, Tablet, 10 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 13107015430", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-507-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Saint Paul", "address_1": "2400 Pilot Knob Rd", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Fagron is recalling six lots due to the presence of mold.", "address_2": "", "product_quantity": "430 jars", "code_info": "Lot # 13J30-U17-015413; Exp 10/15  Lot # 13J30-U16-015425; Exp 10/15  Lot # 13I06-U05-014199;  Exp 10/15", "center_classification_date": "20140730", "distribution_pattern": "Nationwide and Australia", "state": "MN", "product_description": "Fagron, Phytobase Cream, 500 g, Article number:  802156.  RX only, For prescription compounding Natural self-emulsifying oil-in water vehicle for oil-solvents ingredients. Contains Phytosomes (Plant Oil Bodies), Manufactured by Fagron, Inc. 2400 Pilot Knob Rd, St Paul, MN 55120, NDC 51552-1205-6.", "report_date": "20140806", "classification": "Class II", "openfda": {}, "recalling_firm": "Fagron, Inc", "recall_number": "D-1496-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "68896", "termination_date": "20141021", "more_code_info": "", "recall_initiation_date": "20140724", "postal_code": "55120-1118", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Horsham", "address_1": "425 Privet Rd", "reason_for_recall": "CGMP Deviations; laboratory testing was not followed in accordance with GMP requirements", "address_2": "", "product_quantity": "7,694 bottles", "code_info": "TE32134, Exp. 02/15", "center_classification_date": "20140512", "distribution_pattern": "Nationwide", "state": "PA", "product_description": "INDOMETHACIN Capsules USP, 25 mg 100 count bottle, Rx only , Manufactured In INDIA By: EMCURE PHARMACEUTICALS LTD harmaceuticals Ltd., Hinjwadi, Pune, India, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960, NDC 0093-4029-01", "report_date": "20140521", "classification": "Class II", "openfda": {}, "recalling_firm": "Teva Pharmaceuticals USA", "recall_number": "D-1294-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "67811", "termination_date": "20141114", "more_code_info": "", "recall_initiation_date": "20140324", "postal_code": "19044-1220", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Westbury", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69243", "recalling_firm": "Gyma Laboratories Of Amer,Inc", "address_1": "135 Cantiague Rock Rd", "address_2": "N/A", "postal_code": "11590-2826", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0022-2015", "product_description": "Propranolol HCl, NET WT 1 Kg, Rx Only, S.I.M.S. , Chemical Product for Medicines Preparation, Made in Italy, NDC 012660-0004", "product_quantity": "1 Kg", "reason_for_recall": "cGMP Deviations: GYMA laboratories Inc. has recalled multiple Active Pharmaceutical Ingredients manufactured in Italy upon receipt of a Rapid Alert Notification issued by The Italian Medicines Agency due to lack of good manufacturing practices.", "recall_initiation_date": "20140709", "center_classification_date": "20141010", "termination_date": "20180604", "report_date": "20141022", "code_info": "Lot Number: 154919, Exp 11/2014"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {"application_number": ["NDA020936"], "brand_name": ["PAXIL"], "generic_name": ["PAROXETINE HYDROCHLORIDE"], "manufacturer_name": ["Apotex Corp"], "product_ndc": ["60505-4377", "60505-4378", "60505-4379", "60505-3668", "60505-3669", "60505-3670"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PAROXETINE HYDROCHLORIDE"], "rxcui": ["1738803", "1738804", "1738805", "1738806", "1738807", "1738808"], "spl_id": ["57998b73-87c9-7fed-ffa8-7e43620bd98a"], "spl_set_id": ["483bd97f-c4d0-4e23-aaa8-6334f4471e0c"], "package_ndc": ["60505-4377-3", "60505-4378-3", "60505-4379-3", "60505-3668-3", "60505-3669-3", "60505-3670-3"], "is_original_packager": [true], "upc": ["0360505366835", "0360505437733", "0360505366934"], "unii": ["X2ELS050D8"]}, "product_type": "Drugs", "event_id": "68967", "recalling_firm": "Apotex Inc.", "address_1": "150 Signet Drive", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1579-2014", "product_description": "PAXIL CR (Paroxetine HCL) Controlled-Release Tablets 37.5 mg, 30-count bottle, Rx only, Manufactured by GlaxoSmithKline, RTP, NC 27709, Manufactured for Apotex Corp., Weston, FL 33328, NDC 60505-3670-3", "product_quantity": "", "reason_for_recall": "Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.", "recall_initiation_date": "20140324", "center_classification_date": "20140903", "termination_date": "20140923", "report_date": "20140910", "code_info": "Lot # 2E001; Exp. 05/15", "more_code_info": ""}, {"country": "United States", "city": "Jacksonville", "address_1": "4345 Southpoint Blvd", "reason_for_recall": "Temperature Abuse: One shipment was inadvertantly stored refrigerated rather than the labeled room temperature recommendation at McKesson Medical-Surgical Inc., one of the distributing wholesalers.", "address_2": "", "product_quantity": "10 vials", "code_info": "Lot #140502, Exp 10/31/2015", "center_classification_date": "20141003", "distribution_pattern": "McKesson Medical-Surgical Inc distributed to (6) physicians and/or medical facilities in WA, OR, and MT.", "state": "FL", "product_description": "Amiodarone HCl Injection, 450 mg/9 mL (50 mg per mL), 9 mL Single-Use Vial, Rx only, Manufactured for Mylan Institutional, LLC, Rockford, IL 61103, NDC 67457-153-09.", "report_date": "20141015", "classification": "Class II", "openfda": {"application_number": ["ANDA076217"], "brand_name": ["AMIODARONE HYDROCHLORIDE"], "generic_name": ["AMIODARONE HYDROCHLORIDE"], "manufacturer_name": ["Mylan Institutional LLC"], "product_ndc": ["67457-153"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["AMIODARONE HYDROCHLORIDE"], "rxcui": ["1663224", "1663244", "1663248"], "spl_id": ["bd9c578c-322f-41fc-936d-bf9b551a2782"], "spl_set_id": ["fcc8658c-761a-443f-8c32-1499d86028ec"], "package_ndc": ["67457-153-00", "67457-153-03", "67457-153-99", "67457-153-09", "67457-153-18"], "is_original_packager": [true], "unii": ["976728SY6Z"]}, "recalling_firm": "Mckesson", "recall_number": "D-0005-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "69346", "termination_date": "20170417", "more_code_info": "", "recall_initiation_date": "20140912", "postal_code": "32216-6166", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "East Bank Demerara", "state": "", "country": "Guyana", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69206", "recalling_firm": "New Gpc Inc.", "address_1": "Lot A1, Farm", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "New York", "recall_number": "D0034-2015", "product_description": "Whitfield's OINTMENT B.P., Net Contents: 15g.  Manufactured by: NEW GPC INC. A1 Farm, EBD.  Country of Origin Guyana.", "product_quantity": "4320 units", "reason_for_recall": "Does Not Meet Monograph: NEW GPC INC. has recalled multiple Over-the-Counter Drug Products due to lack of drug listing, lack of OTC drug labeling requirements and labeled Not Approved for sale in U.S.A.", "recall_initiation_date": "20140807", "center_classification_date": "20141017", "termination_date": "20180604", "report_date": "20141029", "code_info": "Batch Numbers: 202504, 310455", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: PARICALCITOL, Capsule, 1 mcg may have potentially been mislabeled as one of the following drugs:  ASCORBIC ACID, Tablet, 500 mg, NDC 60258014101, Pedigree: AD23082_19, EXP: 5/6/2014;  CHOLECALCIFEROL, Capsule, 2000 units, NDC 00536379001, Pedigree: W002666, EXP: 6/5/2014.", "address_2": "", "product_quantity": "60 Capsules", "code_info": "PARICALCITOL, Capsule, 1 mcg has the following codes:   Pedigree: AD23082_22, EXP: 5/6/2014;  Pedigree: W002667, EXP: 6/5/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PARICALCITOL, Capsule, 1 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00074431730.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-809-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Horsham", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "66593", "recalling_firm": "Amedra Pharmaceuticals LLC", "address_1": "2 Walnut Grove Dr", "address_2": "Suite 190", "postal_code": "19044-2219", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-385-2014", "product_description": "Dexedrine\u00bf (Dextroamphetamine Sulfate) Spansules\u00bf Sustained Release Capsules 15mg, 90 count bottle, Rx only, Manufactured by Catalent Pharma Solutions Winchester, KY 40391 for Amedra Pharmaceuticals, LLC Middlesex, NJ 08846, NDC 52054-514-09", "product_quantity": "10,992 bottles", "reason_for_recall": "Failed Dissolution Specifications: Out of Specification (OOS) test results for Hour-4 at the 32 month CRT Stability Level.", "recall_initiation_date": "20131007", "center_classification_date": "20131223", "termination_date": "20141007", "report_date": "20140101", "code_info": "Lot#  243459; Exp. 01/14", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: THYROID, Tablet, 60 mg may have potentially been mislabeled as the following drug:  THYROID, Tablet, 30 mg, NDC 00456045801, Pedigree: W002847, EXP: 6/7/2014.", "address_2": "", "product_quantity": "", "code_info": "THYROID, Tablet, 60 mg has the following codes:   Pedigree: W002848, EXP: 6/7/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "THYROID, Tablet, 60 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00456045901.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-914-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "14 units", "code_info": "Rx # 29140, Exp 05/23/14", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Vancomycin 1.25 gm/250 mL 0.9%NS,Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 29140, Discard After 05/23/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1473-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: BROMOCRIPTINE MESYLATE, Tablet, 2.5 mg may have potentially been mislabeled as the following drug:  CYANOCOBALAMIN, Tablet, 1000 mcg, NDC 00904421713, Pedigree: AD32582_3, EXP: 5/9/2014.", "address_2": "", "product_quantity": "30 Tablets", "code_info": "BROMOCRIPTINE MESYLATE, Tablet, 2.5 mg has the following codes:   Pedigree: AD32579_7, EXP: 5/9/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "BROMOCRIPTINE MESYLATE, Tablet, 2.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781532531.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-1011-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Earth City", "address_1": "13600 Shoreline Dr", "reason_for_recall": "Failed Dissolution Specification; at the 6-month stability time point", "address_2": "", "product_quantity": "94,584 cartons", "code_info": "Lot A369286, exp. date 31 Jan 2016", "center_classification_date": "20141017", "distribution_pattern": "Nationwide including Puerto Rico.", "state": "MO", "product_description": "Bystolic (nebivolol) tablets, 20 mg/tablet, packaged as 7 tablets/bottle/carton, and 12 bottles/trays, Professional Sample, Rx only, Forest Pharmaceuticals, Inc., St. Louis, MO. ---  NDC 0456-1420-07", "report_date": "20141029", "classification": "Class II", "openfda": {}, "recalling_firm": "Forest Pharmaceuticals Inc", "recall_number": "D-0036-2015", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "69298", "termination_date": "20170329", "more_code_info": "", "recall_initiation_date": "20140926", "postal_code": "63045-1220", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "67462", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "111 S Calvert St Fl 21st", "address_2": "N/A", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1187-2014", "product_description": "Suprax, Cefixime for Oral Suspension USP, 500 mg/5 ml,  20 mL (when reconstituted), Rx only, Manufactured for Lupin Pharmaceuticals, Inc. 111 South Calvert Street, Baltimore, MD 21202, Manufactured by Lupin Limited Mumbai 400 058 India,  NDC 27437-207-03.", "product_quantity": "5,172 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Product did not meet specification in total impurities at the 9-month stability station.", "recall_initiation_date": "20140127", "center_classification_date": "20140402", "termination_date": "20150512", "report_date": "20140409", "code_info": "Lot #s: F300736 Exp. February 2015, F300740 Exp. February 2015, F300741 Exp. February 2015"}, {"status": "Completed", "city": "Asbury Park", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68158", "recalling_firm": "Flawless Beauty LLC", "address_1": "1215 Main St", "address_2": "", "postal_code": "07712-5940", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-1321-2014", "product_description": "Sterile Water for Injection, 5 mL ampoules, packaged in 50-count ampoules per box, Manufactured and Distributed by: Euro Med Laboratories, UPC 4800573016219", "product_quantity": "unknown", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Product is sold over the counter whose labeling indicates it is to be used for parenteral injection.", "recall_initiation_date": "20140429", "center_classification_date": "20140513", "report_date": "20140521", "code_info": "Lot #: 16U394, Exp 04/16; 16U421, Exp 08/16; 16U423, Exp 09/16", "more_code_info": ""}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA016673"], "brand_name": ["DEXTROSE"], "generic_name": ["DEXTROSE MONOHYDRATE"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["0338-0017", "0338-0023"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["DEXTROSE MONOHYDRATE"], "rxcui": ["1795477", "1795480", "1795481", "1795607", "1795609", "1795610", "1795612", "1795616", "1795618"], "spl_id": ["31bb4a5f-733e-4354-9fbf-138dede4db0f"], "spl_set_id": ["3bb406a9-f5cb-403a-b1bb-5c4facbea3d5"], "package_ndc": ["0338-0017-10", "0338-0017-41", "0338-0017-11", "0338-0017-31", "0338-0017-48", "0338-0017-18", "0338-0017-38", "0338-0017-02", "0338-0017-03", "0338-0017-04", "0338-0023-02", "0338-0023-03", "0338-0023-04"], "is_original_packager": [true], "unii": ["LX22YL083G"]}, "product_type": "Drugs", "event_id": "67092", "recalling_firm": "Baxter Healthcare Corp.", "address_1": "1 Baxter Pkwy", "address_2": "", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Puerto Rico, Singapore, Saudi Arabia and United Arab Emirates.", "recall_number": "D-1162-2014", "product_description": "5% Dextrose Injection, USP, 100 mL Single dose VIAFLEX plastic containers, Rx only, Baxter Healthcare Corporation, Deerfield, IL  60015 USA, Product code 2B0089, NDC 0338-0017-38.", "product_quantity": "105,216 containers", "reason_for_recall": "Presence of Paticulate Matter; Baxter is issuing a voluntary recall for these IV solutions due to particulate matter found in the solution identified as polyester and cotton fibers, adhesive-like mixture, polyacetal particles, thermally degraded PVC, black polypropylene and human hair embedded in the plastic bag", "recall_initiation_date": "20131121", "center_classification_date": "20140314", "termination_date": "20160921", "report_date": "20140326", "code_info": "Lot #: P285288, Exp 11/13", "more_code_info": ""}, {"country": "United States", "city": "South Lyon", "address_1": "350 S Lafayette St", "reason_for_recall": "Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.", "address_2": "", "product_quantity": "33 mL", "code_info": "All unexpired lots, manufactured and distributed between 07/01/2013 and 10/19/2013; including Lot #s: 09182013@42, t09172013@31, t09182013@4", "center_classification_date": "20140110", "distribution_pattern": "Hospitals, clinics, physicians, and patients in the Michigan area only.", "state": "MI", "product_description": "TESTOS CYPIONATE* IN OIL 100 mg/mL INJECTABLE,   TESTOS CYPIONATE* IN OIL 200 mg/mL INJECTABLE, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI 48178", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Specialty Medicine Compounding Pharmacy", "recall_number": "D-449-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "66566", "termination_date": "20140922", "more_code_info": "", "recall_initiation_date": "20131019", "postal_code": "48178-1814", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; MULTIVITAMIN/MULTIMINERAL Tablet may be potentially mislabeled as    PRENATAL MULTIVITAMIN/MULTIMINERAL Tablet, NDC 00904531360, Pedigree: AD73652_16, EXP: 5/30/2014.", "address_2": "", "product_quantity": "200 Tablets", "code_info": "MULTIVITAMIN/MULTIMINERAL Tablet has the following code    Pedigree: AD73646_13, EXP: 5/30/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "MULTIVITAMIN/MULTIMINERAL Tablet, Distributed by: AidaPak Service, LLC, NDC 65162066810", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-709-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; OLANZAPINE, Tablet 7.5 mg may be potentially mislabeled as    NORTRIPTYLINE HCL, Capsule, 75 mg, NDC 00093081301, Pedigree: AD21790_73, EXP: 5/1/2014.", "address_2": "", "product_quantity": "60 Tablets", "code_info": "OLANZAPINE, Tablet, 7.5 mg has the following code    Pedigree: AD21790_76, EXP: 5/1/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "OLANZAPINE, Tablet 7.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 60505311203", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-663-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "68276", "recalling_firm": "Bristol-Meyers Squibb", "address_1": "PO Box 4000", "address_2": "N/A", "postal_code": "08543-4000", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Canada", "recall_number": "D-1595-2014", "product_description": "COUMADIN FOR INJECTION (Warfarin Sodium for Injection, USP 5 mg Single-Use Vial Rx Only Distributed by Bristol Meyers Squibb Company, Princeton, NJ 08543 USA NDC 0590-0324-96", "product_quantity": "50,724 Vials", "reason_for_recall": "Presence of Particulate Matter: particulate matter identified as metallic-like and non-metallic cellulose fiber particles found in retain vials", "recall_initiation_date": "20140512", "center_classification_date": "20140918", "termination_date": "20150529", "report_date": "20140924", "code_info": "Lot 00201125,  Exp. 09/14; 00201126  Exp.11/14; 00201127, Exp.12/14; 00201228 Exp.06/15; 00201229 Exp.  07/15; 00201230, Exp. 09/15", "more_code_info": ""}]